Matt Bonam

I lead Digital Health for BioPharmaceuticals R&D. In Digital Health R&D, we are transforming R&D through digital, data and AI to deliver new digital health solutions to improve outcomes and experience for patients, and to partner with colleagues globally to reimagine healthcare delivery.  

I lead a diverse team focusing on accelerating and differentiating our clinical development programmes through digital health solutions and on the development of digital therapeutics. A recent example is the implementation and scale up of Unify, our new clinical study support platform which is now part of several of our trials around the world. Unify is enabling us to improve remote patient data collection, as well as supporting clinical trial accessibility, diversity and retention. We also work actively with the R&D therapy area teams to explore approaches that can combine our innovative new treatments with evidence-based digital health solutions, such as digital biomarkers, digital diagnostics and digital therapeutics.

A chemist by training, I have been part of the pharmaceutical industry for over 25 years. I have been at AstraZeneca for over 20 years in various roles across R&D and Operations, including as Founder and Head of the Intelligent Pharmaceuticals group, Project Director in Chemistry, Manufacturing and Controls (CMC) and Project Lead roles across different therapy areas.